中医药治疗自身免疫性甲状腺炎的临床疗效与分子机制
本文系统综述中医药及其活性成分治疗自身免疫性甲状腺炎(AIT)的临床疗效与安全性,并探讨其免疫调节的分子机制。文献来源于Web of Science核心合集、PubMed、CNKI等数据库,结果显示中药可干预免疫调节,具有降低抗体、抗炎、抗甲状腺滤泡细胞凋亡、调节肠道菌群及雌孕激素水平等药理作用,涉及Fas/FasL、Caspase、BCL-2、TLRs/MyD88/NF-κB等信号通路。结论认为中药治疗AIT有临床经验、效果满意且安全。
要点
- 中药可多成分多靶点干预AIT的免疫调节。
- 中药具有降低抗体、抗炎、抗凋亡等药理作用。
- 涉及Fas/FasL、Caspase、BCL-2、TLRs/MyD88/NF-κB等通路。
核心结论
- 中药用于AIT的治疗和管理具有临床经验、效果满意且安全。
研究设计与样本
- 综述系统检索Web of Science核心合集、PubMed、CNKI等数据库中与Hashimoto、自身免疫性甲状腺炎、中医药相关的文献。
主要发现
- 越来越多研究表明中药可干预免疫调节,具有降低抗体、抗炎、抗甲状腺滤泡细胞凋亡、调节肠道菌群及调节雌孕激素水平等药理作用。
关键数值与推荐
- 中药免疫调节作用的信号通路和分子靶点可能包括Fas/FasL、Caspase、BCL-2和TLRs/MyD88/NF-κB等。
临床怎么用
- 中药可作为AIT的替代疗法,发挥多成分多靶点免疫调节作用。
局限性
- 未来研究可通过调节免疫因子与传统信号通路间的相互作用评估中药对AIT发生发展的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Autoimmune Thyroiditis (AIT) is a common refractory autoimmune disease of the endocrine system that may eventually lead to complete loss of thyroid function, with subsequent severe effects on the metabolism. Because of the deficiency in current clinical management of AIT, the need for alternative therapies is highlighted. With its multi-component and multi-target characteristics, Chinese medicine has good potential as an alternative therapy for AIT. AIM OF THE STUDY: The aim of this study was to systematically summarize the clinical efficacy and safety evaluation of TCM and its active ingredients in the treatment and regulation of AIT. Additionally, we provide an in-depth discussion of the relevant mechanisms and molecular targets to understand the protective effects of traditional Chinese medicine on AIT and explore new ideas for clinical treatment. MATERIALS AND METHODS: The literature related to "Hashimoto", "autoimmune thyroiditis", "traditional Chinese medicine," and "Chinese herbal medicine" was systematically summarized and reviewed from Web of Science Core Collection, PubMed, CNKI, and other databases. Domestic and international literature were analyzed, compared, and reviewed. RESULTS: An increasing number of studies have demonstrated that herbal medicines can intervene in immunomodulation, with pharmacological effects such as antibody lowering, anti-inflammatory, anti-apoptotic thyroid follicular cells, regulation of intestinal flora, and regulation of estrogen and progesterone levels. The signaling pathways and molecular targets of the immunomodulatory effects of Chinese herbal medicine for AIT may include Fas/FasL, Caspase, BCL-2, and TLRs/MyD88/NF-κB et al. CONCLUSIONS: The use of Chinese herbs in the treatment and management of AIT is clinically experienced, satisfactory, and safe. Future studies may evaluate the influence of herbal medicines on the occurrence and development of AIT by modulating the interaction between immune factors and conventional signaling pathways.
引用
- Zhou L, Luo JL, Sun A, et al. Clinical efficacy and molecular mechanism of Chinese medicine in the treatment of autoimmune thyroiditis. J Ethnopharmacol. 2023. PMID: 38160869. doi:10.1016/j.jep.2023.117689
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。